Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
- Generic Name
- Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen
- Brand Names
- Menactra
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 2J57K2523T
Overview
Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine contains N. meningitis serogroup c capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
Background
Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup c. The vaccine contains N. meningitis serogroup c capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.
Indication
No indication information available.
Associated Conditions
- Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup C
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.